Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

December 15, 2007

Primary Completion Date

September 4, 2017

Study Completion Date

February 28, 2018

Conditions
Liver CancerOtotoxicity
Interventions
DRUG

cisplatin

DRUG

sodium thiosulfate

Trial Locations (16)

B4 6NH

Birmingham Children's Hospital, Birmingham

BS2 8AE

Bristol Royal Hospital for Childre, Bristol

CB2 2QQ

Addenbrooke's Hospital, Cambridge

SW3 6JJ

Royal Marsden - London, London

WC1N 3JH

Great Ormond Street Hospital for Children, London

M27 4HA

Royal Manchester Children's Hospital, Manchester

NG7 2UH

Queen's Medical Centre, Nottingham

S1 1WB

Sheffield Hallam University - City Campus, Sheffield

AB25 2ZG

Royal Aberdeen Children's Hospital, Aberdeen

G3 8SJ

Royal Hospital for Sick Children, Glasgow

Unknown

The Noah's Ark Children's Hospital for Wales, Cardiff

Royal Hospital For Sick Children, Edinburgh

Leicester Royal Infirmary, Leicester

Alder Hey Children's Hospital Trust, Liverpool

John Radcliffe Hospital, Oxford

Southampton Children's Hospital, Southampton

All Listed Sponsors
collaborator

Childhood Liver Tumours Strategy Group - SIOPEL

UNKNOWN

lead

University of Birmingham

OTHER

NCT00652132 - Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer | Biotech Hunter | Biotech Hunter